MetLife, Inc. $MET Shares Bought by Mitsubishi UFJ Asset Management Co. Ltd.

Mitsubishi UFJ Asset Management Co. Ltd. lifted its stake in shares of MetLife, Inc. (NYSE:MET) by 3.6% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,088,916 shares of the financial services provider’s stock after acquiring an additional 37,995 shares during the quarter. Mitsubishi UFJ Asset Management Co. Ltd. owned about 0.16% of MetLife worth $87,571,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in the company. Csenge Advisory Group raised its stake in shares of MetLife by 1.0% in the 1st quarter. Csenge Advisory Group now owns 13,647 shares of the financial services provider’s stock worth $1,096,000 after buying an additional 131 shares in the last quarter. Delta Investment Management LLC grew its holdings in MetLife by 0.9% during the first quarter. Delta Investment Management LLC now owns 14,265 shares of the financial services provider’s stock worth $1,145,000 after acquiring an additional 133 shares during the period. Ignite Planners LLC raised its position in MetLife by 2.2% in the second quarter. Ignite Planners LLC now owns 6,366 shares of the financial services provider’s stock worth $491,000 after acquiring an additional 136 shares in the last quarter. Glenview Trust co lifted its holdings in MetLife by 0.4% in the 1st quarter. Glenview Trust co now owns 38,333 shares of the financial services provider’s stock valued at $3,078,000 after acquiring an additional 141 shares during the last quarter. Finally, Whittier Trust Co. of Nevada Inc. boosted its position in shares of MetLife by 1.0% during the 2nd quarter. Whittier Trust Co. of Nevada Inc. now owns 14,902 shares of the financial services provider’s stock valued at $1,198,000 after purchasing an additional 148 shares in the last quarter. 94.99% of the stock is currently owned by institutional investors and hedge funds.

MetLife Stock Up 0.2%

NYSE:MET opened at $76.11 on Monday. MetLife, Inc. has a 1-year low of $65.21 and a 1-year high of $89.05. The firm has a market capitalization of $50.62 billion, a price-to-earnings ratio of 12.90, a PEG ratio of 0.70 and a beta of 0.87. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.57. The business’s fifty day moving average price is $80.04 and its 200 day moving average price is $78.86.

MetLife (NYSE:MET) last released its earnings results on Wednesday, November 5th. The financial services provider reported $2.37 earnings per share for the quarter, beating the consensus estimate of $2.30 by $0.07. MetLife had a return on equity of 19.88% and a net margin of 5.83%.The company had revenue of $12.46 billion for the quarter, compared to analysts’ expectations of $18.64 billion. During the same quarter in the previous year, the business posted $1.95 EPS. The business’s revenue for the quarter was down 5.9% on a year-over-year basis. On average, sell-side analysts forecast that MetLife, Inc. will post 9.65 earnings per share for the current fiscal year.

MetLife Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 9th. Investors of record on Tuesday, November 4th will be given a dividend of $0.5675 per share. The ex-dividend date of this dividend is Tuesday, November 4th. This represents a $2.27 dividend on an annualized basis and a yield of 3.0%. MetLife’s dividend payout ratio (DPR) is presently 42.75%.

Analyst Upgrades and Downgrades

A number of research firms recently commented on MET. Barclays boosted their target price on shares of MetLife from $93.00 to $98.00 and gave the stock an “overweight” rating in a report on Wednesday, October 8th. Wells Fargo & Company cut their price objective on MetLife from $96.00 to $92.00 and set an “overweight” rating for the company in a research report on Friday. Weiss Ratings reissued a “buy (b)” rating on shares of MetLife in a research note on Wednesday, October 8th. Piper Sandler lowered MetLife from an “overweight” rating to a “neutral” rating and set a $84.00 target price on the stock. in a research report on Friday, September 19th. Finally, Keefe, Bruyette & Woods decreased their price target on MetLife from $94.00 to $92.00 and set an “outperform” rating for the company in a research report on Monday, August 11th. One research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $95.18.

MetLife Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.